Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers Discover Effective Method For Killing Prostate Cancer Cells

30.04.2003


By blocking a protein key to prostate cancer cell growth, researchers at the Lombardi Cancer Center at Georgetown University have discovered a way to trigger extensive prostate cancer cell death. This finding opens a new window for developing targeted treatments aimed at destroying prostate cancer cells before they have the opportunity to grow or spread. The study is published in the April 29 online issue of the Journal of Biological Chemistry.



“By preventing the Stat5 protein from being active, we were able to effectively kill human prostate cells,” said Marja Nevalainen, MD, PhD, assistant professor of oncology at Georgetown University Medical Center. "It’s similar to using a weed killer -- poison ivy cannot take over the backyard if we don’t allow the leaves to breathe. If we stop this protein, which in turn stops the growth of prostate cancer cells, we are one step closer to managing the spread and growth of cancer in the prostate.”

Recent understanding of the correlation between prolactin, a hormone produced by male and female pituitary glands, and how it promotes growth of cells in the prostate led to this new study. Pioneering work by Dr. Nevalainen and colleagues established that prolactin serves as a local growth factor for prostate cells and that Stat5 is the specific signaling device for prolactin in prostate cells. In other words, Stat5 acts as an internal signaling device within the cell, receiving and sending messages of prolactin to the cell’s DNA.


In the new study, Nevalainen explored what happens if the activation of Stat5 in prostate cancer cells is blocked. Using human prostate cancer cell lines and viral gene delivery of an inhibitory mutant of Stat5, Nevalainen and her colleagues found that blocking the activity of this protein in prostate cancer cells will trigger extensive cell death.

“Once prostate cancer has metastasized, or spread, men have few treatment options other than chemotherapy and radiation,” said Nevalainen. “This finding could certainly lead to the development of new targeted therapeutics that can put the brakes on the growth of prostate cancer cells, allowing us to kill tumor cells, reduce the volume of tumors, and kill already metastasized cells.”

This study was funded by the National Cancer Institute (NCI).

Prostate cancer is the second leading cause of cancer death in men, exceeded only by lung cancer. According to the American Cancer Society, prostate cancer is the most common type of cancer found in American men, other than skin cancer. The ACS estimates that there will be about 220,900 new cases of prostate cancer in the United States in the year 2003. About 28,900 men will die of this disease. African-American men are disproportionately affected by the disease.

Lindsey Spindle | georgetown news
Further information:
http://www.georgetown.edu/gumc
http://gumc.georgetown.edu/communications/releases/release.cfm?ObjectID=274

More articles from Health and Medicine:

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

nachricht Study advances gene therapy for glaucoma
17.01.2018 | University of Wisconsin-Madison

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Polymers Based on Boron?

18.01.2018 | Life Sciences

Bioengineered soft microfibers improve T-cell production

18.01.2018 | Life Sciences

World’s oldest known oxygen oasis discovered

18.01.2018 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>